Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycophorin A inhibits lysis by the complement attack phase.

H Brauch, D Roelcke, U Rother

    Immunobiology
    |August 1, 1983
    PubMed
    Summary

    Glycophorin A, a protein from red blood cells, stops the complement system’s cell-killing components (C5-C9) from destroying cells. This finding suggests glycophorin A regulates complement-mediated lysis of human cells.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Diabetic foot syndrome-Part 2 : Revascularization, treatment alternatives, care structures, recurrency prophylaxis].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2020
    Same author

    [Diabetic foot syndrome-Part 1 : Definition, pathophysiology, diagnostics and classification].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2020
    Same author

    Noninvasive measurements of tissue perfusion in critical limb ischemia.

    Gefasschirurgie : Zeitschrift fur vaskulare und endovaskulare Chirurgie : Organ der Deutschen und der Osterreichischen Gesellschaft fur Gefasschirurgie unter Mitarbeit der Schweizerischen Gesellschaft fur Gefasschirurgie·2018
    Same author

    Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.

    Breast cancer research and treatment·2015
    Same author

    Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.

    The pharmacogenomics journal·2014
    Same author

    FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

    British journal of cancer·2014

    Area of Science:

    • Immunology
    • Cell Biology
    • Biochemistry

    Background:

    • The complement system is a crucial part of innate immunity.
    • Complement-mediated cell lysis involves terminal attack components C5-C9.
    • Regulatory mechanisms of complement attack on host cells are not fully understood.

    Purpose of the Study:

    • To identify molecules on human erythrocyte membranes that inhibit complement-mediated lysis.
    • To investigate the role of glycophorin A in regulating the complement cascade.

    Main Methods:

    • Purification of inhibitory glycoproteins from human erythrocyte membranes.
    • Functional assays to assess inhibition of C5-C9 mediated lysis.
    • Protein identification techniques.

    Main Results:

    • A glycoprotein inhibitor of C5-C9 mediated lysis was isolated from human erythrocyte membranes.
    • The identified inhibitor was confirmed to be glycophorin A.
    • Glycophorin A demonstrated significant inhibition of target cell lysis by complement attack components.

    Conclusions:

    • Glycophorin A possesses inhibitory activity against the terminal complement complex (C5-C9).
    • Glycophorin A may serve as a natural regulator of complement-mediated lysis on isologous (self) cells.
    • This discovery sheds light on host-protective mechanisms against autologous complement activation.

    Related Experiment Videos